NFKB1 and breast carcinoma: Conversely, the TNFα signaling pathway via the NF-κB pathway exhibited a significant negative association with WNTHigh cells (Fig. 2E), aligning with previous findings suggesting that active β-catenin can attenuate transcriptional NF-κB activity in breast cancer (35).